 |
The Journal of Neuroscience, November 30, 2005, 25(48):11061-11070; doi:10.1523/JNEUROSCI.3034-05.2005
Previous Article | Next Article 
Neurobiology of Disease
Soluble -Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses
F. Roselli,1,2
M. Tirard,1
J. Lu,1
P. Hutzler,3
P. Lamberti,2
P. Livrea,2
M. Morabito,4 and
O. F. X. Almeida1
1Max Planck Institute of Psychiatry, 80804 Munich, Germany, 2Department of Neurological and Psychiatric Sciences, University of Bari, 70124 Bari, Italy, 3Institute of Pathology, GSF National Research Center for Environment and Health, 85764 Neuherberg, Germany, and 4Department of Cell Biology, University of Massachusetts Medical School, E. K. Shriver Center, Waltham, Massachusetts 02452
Amyloid- (A ) has been implicated in memory loss and disruption of synaptic plasticity observed in early-stage Alzheimer's disease. Recently, it has been shown that soluble A oligomers target synapses in cultured rat hippocampal neurons, suggesting a direct role of A in the regulation of synaptic structure and function. Postsynaptic density-95 (PSD-95) is a postsynaptic scaffolding protein that plays a critical role in synaptic plasticity and the stabilization of AMPA (AMPARs) and NMDA (NMDARs) receptors at synapses. Here, we show that exposure of cultured cortical neurons to soluble oligomers of A 1-40 reduces PSD-95 protein levels in a dose- and time-dependent manner and that the A 11-40-dependent decrease in PSD-95 requires NMDAR activity. We also show that the decrease in PSD-95 requires cyclin-dependent kinase 5 activity and involves the proteasome pathway. Immunostaining analysis of cortical cultured neurons revealed that A treatment induces concomitant decreases in PSD-95 at synapses and in the surface expression of the AMPAR glutamate receptor subunit 2. Together, these data suggest a novel pathway by which A triggers synaptic dysfunction, namely, by altering the molecular composition of glutamatergic synapses.
Key words: phosphorylation; glutamate receptor; metabotropic glutamate receptor; AMPA receptor; synaptic plasticity; amyloid ; A peptide; NMDA receptor; PSD-95; proteasome; cdk5
Received July 22, 2005;
revised October 4, 2005;
accepted October 15, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
R. Williamson, A. Usardi, D. P. Hanger, and B. H. Anderton
Membrane-bound {beta}-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism
FASEB J,
May 1, 2008;
22(5):
1552 - 1559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Petratos, Q.-X. Li, A. J. George, X. Hou, M. L. Kerr, S. E. Unabia, I. Hatzinisiriou, D. Maksel, M.-I. Aguilar, and D. H. Small
The -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism
Brain,
January 1, 2008;
131(1):
90 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Spires-Jones, M. Meyer-Luehmann, J. D. Osetek, P. B. Jones, E. A. Stern, B. J. Bacskai, and B. T. Hyman
Impaired Spine Stability Underlies Plaque-Related Spine Loss in an Alzheimer's Disease Mouse Model
Am. J. Pathol.,
October 1, 2007;
171(4):
1304 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Waxman, I. Baconguis, D. R. Lynch, and M. B. Robinson
N-Methyl-D-aspartate Receptor-dependent Regulation of the Glutamate Transporter Excitatory Amino Acid Carrier 1
J. Biol. Chem.,
June 15, 2007;
282(24):
17594 - 17607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Priller, I. Dewachter, N. Vassallo, S. Paluch, C. Pace, H. A. Kretzschmar, F. Van Leuven, and J. Herms
Mutant Presenilin 1 Alters Synaptic Transmission in Cultured Hippocampal Neurons
J. Biol. Chem.,
January 12, 2007;
282(2):
1119 - 1127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Ting, B. G. Kelley, T. J. Lambert, D. G. Cook, and J. M. Sullivan
Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms
PNAS,
January 2, 2007;
104(1):
353 - 358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wu, Z. Wu, P. Butko, Y. Christen, M. P. Lambert, W. L. Klein, C. D. Link, and Y. Luo
Amyloid-{beta}-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans
J. Neurosci.,
December 13, 2006;
26(50):
13102 - 13113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Capetillo-Zarate, M. Staufenbiel, D. Abramowski, C. Haass, A. Escher, C. Stadelmann, H. Yamaguchi, O. D. Wiestler, and D. R. Thal
Selective vulnerability of different types of commissural neurons for amyloid {beta}-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology
Brain,
November 1, 2006;
129(11):
2992 - 3005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Huang, A. Mouri, H. Kokubo, R. Nakajima, T. Suemoto, M. Higuchi, M. Staufenbiel, Y. Noda, H. Yamaguchi, T. Nabeshima, et al.
Neprilysin-sensitive Synapse-associated Amyloid-beta Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function
J. Biol. Chem.,
June 30, 2006;
281(26):
17941 - 17951.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|